Clinical evaluation of the effects of combined treatment with bromocriptine and spironolactone in two women with the polycystic ovary syndrome
Authors:
- Ilana BlumIBIlana Blum
- Shelly BruhisSBShelly Bruhis
- Hayuta KaufmanHKHayuta Kaufman
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 35 (6) , 629-633
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tonic Dopaminergic Suppression of Plasma Aldosterone*The Journal of Clinical Endocrinology & Metabolism, 1980
- BromocriptineNew England Journal of Medicine, 1979
- The Effects of Ovariectomy and Estrogen Treatment on the Dopamine Inhibition of Gonadotropin and Prolactin Release*The Journal of Clinical Endocrinology & Metabolism, 1979
- Effect of Metoclopramide, a Dopaminergic Inhibitor, on Renin and Aldosterone in Idiopathic Edema: Possible Therapeutic Approach with Levodopa and CarbidopaThe Journal of Clinical Endocrinology & Metabolism, 1979
- Spironolactone Therapy for Hirsutism in a Hyperandrogenic WomanAnnals of Internal Medicine, 1978
- Interaction of Digitalis and Spironolactone with Human Sex Steroid ReceptorsThe Journal of Clinical Endocrinology & Metabolism, 1978
- BROMOCRIPTINE FOR INDUCTION OF OVULATION IN NORMOPROLACTINÆMIC POST-PILL ANOVULATIONThe Lancet, 1977
- Bromocriptine treatment of female infertility: report of 13 pregnancies.BMJ, 1975
- Dopamine — Clinical Uses of an Endogenous CatecholamineNew England Journal of Medicine, 1974
- BLOCKING THE RENAL ELECTROLYTE EFFECTS OF MINERALOCORTICOIDS WITH AN ORALLY ACTIVE STEROIDAL SPIROLACTONEEndocrinology, 1960